Key regulator PNPLA8 drives phospholipid reprogramming induced proliferation and migration in triple-negative breast cancer

被引：0
|
作者：
Zheqiong Tan
Pragney Deme
Keerti Boyapati
Britt S. R. Claes
Annet A. M. Duivenvoorden
Ron M. A. Heeren
Caitlin M. Tressler
Norman James Haughey
Kristine Glunde
机构：
[1] Johns Hopkins University School of Medicine,Russell H. Morgan Department of Radiology and Radiological Science, Division of Cancer Imaging Research
[2] Tongji Medical College,Department of Medical Laboratory, The Central Hospital of Wuhan
[3] Huazhong University of Science and Technology,Department of Neurology
[4] Johns Hopkins University School of Medicine,Maastricht MultiModal Molecular Imaging Institute
[5] Maastricht University,Department of Surgery, NUTRIM School of Nutrition and Translational Research in Metabolism
[6] Maastricht University,Department of Psychiatry
[7] Johns Hopkins University School of Medicine,Sidney Kimmel Comprehensive Cancer Center
[8] Johns Hopkins University School of Medicine,Department of Biological Chemistry
[9] Johns Hopkins University School of Medicine,undefined
来源：
Breast Cancer Research | / 25卷
关键词：
PNPLA8; Breast cancer; Triple negative; Phospholipid; Metabolism reprogramming; Eicosanoids; Migration; Invasion; Proliferation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Key regulator PNPLA8 drives phospholipid reprogramming induced proliferation and migration in triple-negative breast cancer
    Tan, Zheqiong
    Deme, Pragney
    Boyapati, Keerti
    Claes, Britt S. R.
    Duivenvoorden, Annet A. M.
    Heeren, Ron M. A.
    Tressler, Caitlin M.
    Haughey, Norman James
    Glunde, Kristine
    BREAST CANCER RESEARCH, 2023, 25 (01)
  • [2] MerTK Drives Proliferation and Metastatic Potential in Triple-Negative Breast Cancer
    Iida, Mari
    Crossman, Bridget E.
    Kostecki, Kourtney L.
    Glitchev, Christine E.
    Kranjac, Carlene A.
    Crow, Madisen T.
    Adams, Jillian M.
    Liu, Peng
    Ong, Irene
    Yang, David T.
    Kang, Irene
    Salgia, Ravi
    Wheeler, Deric L.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (10)
  • [3] Metabolic reprogramming in triple-negative breast cancer
    Zhanyu Wang
    Qianjin Jiang
    Chenfang Dong
    Cancer Biology & Medicine , 2020, (01) : 44 - 59
  • [4] Metabolic reprogramming in triple-negative breast cancer
    Zhanyu Wang
    Qianjin Jiang
    Chenfang Dong
    Cancer Biology & Medicine, 2020, 17 (01) : 44 - 59
  • [5] Metabolic reprogramming in triple-negative breast cancer
    Wang, Zhanyu
    Jiang, Qianjin
    Dong, Chenfang
    CANCER BIOLOGY & MEDICINE, 2020, 17 (01) : 44 - 59
  • [6] Metabolic Reprogramming in Triple-Negative Breast Cancer
    Sun Xiangyu
    Wang Mozhi
    Wang Mengshen
    Yu Xueting
    Guo Jingyi
    Sun Tie
    Li Xinyan
    Yao Litong
    Dong Haoran
    Xu Yingying
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [7] Interleukin 8 in triple-negative breast cancer
    Bogomazova, S.
    Popova, O.
    Danilova, T.
    Ivanov, A.
    VIRCHOWS ARCHIV, 2017, 471 : S53 - S53
  • [8] Upregulation of MGP by HOXC8 promotes the proliferation, migration, and EMT processes of triple-negative breast cancer
    Gong, Chen
    Zou, Jin
    Zhang, Mingsheng
    Zhang, Jie
    Xu, Shanshan
    Zhu, Siqi
    Yang, Mengqi
    Li, Dongjia
    Wang, Yun
    Shi, Jialu
    Li, Yong
    MOLECULAR CARCINOGENESIS, 2019, 58 (10) : 1863 - 1875
  • [9] Using epigenetic reprogramming to target triple-negative breast cancer
    Sharma, D.
    Knight, B. B.
    Yacoub, R.
    Liu, T.
    Taliaferro-Smith, L.
    Nagalingam, A.
    O'Regan, R. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [10] Calsequestrin 2 regulates proliferation, migration, and invasion in triple-negative breast cancer cells
    Kim, Ju Hee
    Hong, Bok Sil
    Heo, Woohang
    Han, Jong Min
    Han, Wonsik
    Noh, Dong-Young
    Moon, Hyeong-Gon
    CANCER RESEARCH, 2018, 78 (13)
12345